These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 15802227)
21. Recombinant Bordetella pertussis pertactin (P69) from the yeast Pichia pastoris: high-level production and immunological properties. Romanos MA; Clare JJ; Beesley KM; Rayment FB; Ballantine SP; Makoff AJ; Dougan G; Fairweather NF; Charles IG Vaccine; 1991 Dec; 9(12):901-6. PubMed ID: 1811375 [TBL] [Abstract][Full Text] [Related]
22. Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines. Hegerle N; Guiso N Expert Rev Vaccines; 2014 Sep; 13(9):1135-46. PubMed ID: 24953157 [TBL] [Abstract][Full Text] [Related]
23. Clinical Manifestations and Molecular Characterization of Pertactin-Deficient and Pertactin-Producing Bordetella pertussis in Children, Philadelphia 2007-2014. Vodzak J; Queenan AM; Souder E; Evangelista AT; Long SS Clin Infect Dis; 2017 Jan; 64(1):60-66. PubMed ID: 27624959 [TBL] [Abstract][Full Text] [Related]
24. The preparation of A purified immunogenic pertactin from B. pertussis. El-Kady EM; Abu-Shady HM; Tohamy HS; Wahby AF Egypt J Immunol; 2007; 14(2):11-8. PubMed ID: 20306653 [TBL] [Abstract][Full Text] [Related]
25. Synergic effect of genotype changes in pertussis toxin and pertactin on adaptation to an acellular pertussis vaccine in the murine intranasal challenge model. Komatsu E; Yamaguchi F; Abe A; Weiss AA; Watanabe M Clin Vaccine Immunol; 2010 May; 17(5):807-12. PubMed ID: 20357056 [TBL] [Abstract][Full Text] [Related]
26. Expression of P.69/pertactin from Bordetella pertussis in a baculovirus/insect cell expression system: protective properties of the recombinant protein. Charles I; Rodgers B; Musgrave S; Peakman TC; Chubb A; Fairweather N; Dougan G; Roberts M Res Microbiol; 1993; 144(9):681-90. PubMed ID: 8190994 [TBL] [Abstract][Full Text] [Related]
27. Evolution of French Bordetella pertussis and Bordetella parapertussis isolates: increase of Bordetellae not expressing pertactin. Hegerle N; Paris AS; Brun D; Dore G; Njamkepo E; Guillot S; Guiso N Clin Microbiol Infect; 2012 Sep; 18(9):E340-6. PubMed ID: 22717007 [TBL] [Abstract][Full Text] [Related]
28. Hybrid genes over-express pertactin from Bordetella pertussis. Loosmore SM; Yacoob RK; Zealey GR; Jackson GE; Yang YP; Chong PS; Shortreed JM; Coleman DC; Cunningham JD; Gisonni L Vaccine; 1995 Apr; 13(6):571-80. PubMed ID: 7483778 [TBL] [Abstract][Full Text] [Related]
29. Rapid identification of Bordetella pertussis pertactin gene variants using LightCycler real-time polymerase chain reaction combined with melting curve analysis and gel electrophoresis. Mäkinen J; Viljanen MK; Mertsola J; Arvilommi H; He Q Emerg Infect Dis; 2001; 7(6):952-8. PubMed ID: 11747721 [TBL] [Abstract][Full Text] [Related]
30. Expression of the Bordetella pertussis P.69 pertactin adhesin in Escherichia coli: fate of the carboxy-terminal domain. Charles I; Fairweather N; Pickard D; Beesley J; Anderson R; Dougan G; Roberts M Microbiology (Reading); 1994 Dec; 140 ( Pt 12)():3301-8. PubMed ID: 7881548 [TBL] [Abstract][Full Text] [Related]
31. Antimicrobial Susceptibility and Molecular Detection of Pertactin-producing and Pertactin-Deficient Bordetella pertussis. Souder E; Vodzak J; Evangelista AT; Long SS Pediatr Infect Dis J; 2017 Jan; 36(1):119-121. PubMed ID: 27956730 [TBL] [Abstract][Full Text] [Related]
32. Pertactin-negative variants of Bordetella pertussis in New York State: a retrospective analysis, 2004-2013. Quinlan T; Musser KA; Currenti SA; Zansky SM; Halse TA Mol Cell Probes; 2014 Aug; 28(4):138-40. PubMed ID: 24365130 [TBL] [Abstract][Full Text] [Related]
33. Antigenic divergence suggested by correlation between antigenic variation and pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates in Japan. Kodama A; Kamachi K; Horiuchi Y; Konda T; Arakawa Y J Clin Microbiol; 2004 Dec; 42(12):5453-7. PubMed ID: 15583264 [TBL] [Abstract][Full Text] [Related]
34. [Antigenic variability of Bordetella pertussis strains isolated in 1967-2010 in the Czech Republic--possible explanation for the rise in cases of pertussis?]. Zavadilová J; Lžičařová D; Musílek M; Křížová P; Fabiánová K Epidemiol Mikrobiol Imunol; 2015 Sep; 64(3):130-8. PubMed ID: 26448300 [TBL] [Abstract][Full Text] [Related]
35. Production of recombinant Bordetella pertussis serotype 2 fimbriae in Bordetella parapertussis and Bordetella bronchiseptica: utility of Escherichia coli gene expression signals. Walker MJ; Guzmán CA; Rohde M; Timmis KN Infect Immun; 1991 May; 59(5):1739-46. PubMed ID: 1708358 [TBL] [Abstract][Full Text] [Related]
37. Genome characteristics of Ben Fraj I; Bouchez V; Smaoui H; Kechrid A; Brisse S J Med Microbiol; 2019 Sep; 68(9):1320-1323. PubMed ID: 31329091 [TBL] [Abstract][Full Text] [Related]
38. Crystallization and preliminary X-ray diffraction analysis of P30, the transmembrane domain of pertactin, an autotransporter from Bordetella pertussis. Zhu Y; Black I; Roszak AW; Isaacs NW Acta Crystallogr Sect F Struct Biol Cryst Commun; 2007 Jul; 63(Pt 7):593-5. PubMed ID: 17620719 [TBL] [Abstract][Full Text] [Related]
39. [Evaluation of whole-cell and acellular pertussis vaccines effectiveness in clearance of experimental B. pertussis infection in mice]. Gzyl A; Augustynowicz E; Zawadka M; Rabczenko D; Slusarczyk J Med Dosw Mikrobiol; 2007; 59(2):123-35. PubMed ID: 17929410 [TBL] [Abstract][Full Text] [Related]
40. Adaptive evolution of the Bordetella autotransporter pertactin. Diavatopoulos DA; Hijnen M; Mooi FR J Evol Biol; 2006 Nov; 19(6):1931-8. PubMed ID: 17040390 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]